Teva UK has launched generic Tolterodine 1mg and 2mg film-coated tablets, and Tolterodine XL (Mariosea XL) 4mg capsules.
Tolterodine is a generic version of Detrusitol (tolterodine) while Tolterodine XL (Mariosea XL) is a generic version of Detrusitol XL (tolterodine XL) from Pfizer, both indicated for the symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
The company announces the availability of the products in the Teva 360 livery.
Teva commercial director Kim Innes said the company is making more medicines accessible for more people with the launch of tolterodine in all strengths and formulations.
"We've now launched twenty-four new products in 2012, and the launch of tolterodine is our twelfth patent expiry of the year so far," Innes added.
"More than 1.2 million prescriptions are written each year in the UK for tolterodine or tolterodine XL, and the availability of generic tolterodine will save the NHS millions of pounds each year."
